USCB USCB FINANCIAL HOLDINGS, INC. Insider Trading

USCB CEO Luis De La Aguilera sold 49,414 shares at $18.30; stock down 3.8% in 30 days, 4.6% in 90 days

La Aguilera Luis De, USCB's President and CEO, sold 49,414 shares (49.4K shares) for $904,276.20 on 2026-05-21 at $18.30, reducing his holdings by 16.9% to 242,945 shares. The sale occurred as the stock has declined 3.8% over the prior 30 days and 4.6% over 90 days, currently trading at $18.60, which is 10.5% below the 52-week high of $20.78. His five prior open-market sales at USCB have all coincided with subsequent 30-day and 90-day gains (ranging 1.9% to 2.9%), yet none were well-timed at the 90-day mark (meaning the stock rose after each prior sale, not fell). This current sale follows that same pattern: stock weakness after the sale, but without data on post-transaction returns, the question remains whether this represents a continuation of that pattern or a departure.

USCB CEO De La Aguilera sold 41,757 shares ($757.2K) over 2 days; holdings fell 14.7% to 242.9K shares.

La Aguilera Luis De (President and CEO) executed two separate sales totaling 41,757 shares for $757,199.21, reducing holdings from 284,702 to 242,945 shares (-14.7%). The sales on 2026-05-19 and 2026-05-20 were priced at $18.01 and $18.15, while the stock currently trades at $18.34, placing the transaction near recent levels. His prior four sales at USCB show a 0% well-timed rate at the 90-day mark (all were followed by stock gains), and the cross-ticker track record shows 0.00% well-timed rate across 4 prior sells. The magnitude of the position reduction in a single filing warrants investor attention, though at a P/E of 12.07 and net income of $9,351,000.00, the company presents moderate valuation metrics.

USCB CEO Luis De La Aguilera sold 42,830 shares for $776,713.42 over two days at prices ranging from $12.05 to $18.20.

Luis De La Aguilera, President and CEO, executed four separate sales across May 13–14, 2026, disposing of 42,830 shares totaling $776,713.42 at prices spanning $12.05 to $18.20, reducing his holdings from 285.8K to 242.9K shares. His prior four sales at USCB—all within the past year—produced mixed results: 90-day returns of +1.0%, +1.2%, +0.6%, and +2.7%, meaning none preceded a stock decline at the 90-day horizon. The current stock price of $18.02 sits 13.3% below the 52-week high of $20.78 and has declined 8.9% over 30 days and 8.7% over 90 days, placing this sale in the context of recent weakness. With a P/E of 11.86 and market cap of $329.1M, the company trades at a modest valuation multiple, and the insider retains a substantial 242.9K share position post-transaction.

USCB CEO Luis De La Aguilera executes paired buy-sell trades within two days; simultaneous buying and selling requires scrutiny.

On consecutive business days, Luis De La Aguilera, USCB's President and CEO, executed four transactions in rapid succession: purchasing approximately 30,000 shares while simultaneously selling the same volume at higher prices, capturing roughly $114,000 in apparent gains over two days. This simultaneous buy-sell pattern is unusual for a chief executive and raises questions about trading rationale—whether this represents portfolio rebalancing, liquidity management, or opportunistic trading around price spreads. The company remains financially sound with solid profitability and a reasonable valuation, but the stock has declined meaningfully over the past three months and remains well below its recent highs, which makes the timing of these purchases less obviously attractive than buying during earlier strength would have been. De La Aguilera's prior sales in this stock have not demonstrated strong timing; his most recently evaluable prior sale saw the stock recover over a longer horizon, suggesting his prior exits were not optimally timed. The paired structure and rapid execution distinguish this filing from routine insider trades and warrant examination of whether this reflects operational confidence or portfolio housekeeping.

Director Wycoff W Kirk sold 82,043 shares of USCB at $18.56; holds 1,895,286 post-transaction.

Director Wycoff W Kirk sold 82,043 shares on 2025-12-10 at $18.56, reducing his holdings by 4.1% to 1,895,286 shares. The sale occurred at a price $0.12 below the current market price of $18.68 and near the top of the 52-week range ($15.78–$20.00), with the stock up 4.6% over 30 days and 7.6% over 90 days. USCB trades at a P/E of 10.67 against net income of $8,939,000, with a market cap of $338,301,991.80. The transaction represents a discrete reduction in an already-substantial stake but does not signal a dramatic confidence shift given the director's continued material ownership post-sale.

CEO Luis de la Aguilera sold 30,000 shares at blended $16.74 for $502,200 on May 21-22; stock down 19.9% from 52-week high.

Luis de la Aguilera, President and CEO of USCB Financial Holdings, executed 2 separate sales totaling 30,000 shares for $502,200.00 over two days, reducing his post-transaction holdings to 238,974 shares. The sales occurred at $16.94 (May 21) and $16.70 (May 22), yielding a blended average price of $16.74, while the stock currently trades at $16.65, only 9 basis points below the transaction window. The company has a reasonable P/E of 12.07 and net income of $7,658,000.00, though the stock has declined 19.9% from its 52-week high of $20.78 and is down 8.1% over the last 30 days, suggesting recent headwinds in the market's valuation of the company. The CEO's 11.2% reduction in holdings occurs against this backdrop of share-price depreciation, though the proximity of transaction prices to current price suggests the sales were not notably mistimed relative to present conditions.

Director Rodriguez doubles USCB holding to 12.0K shares with $87.7K buy at $14.61; 4 of 4 prior USCB buys well-timed at 90-day mark

Rodriguez purchased 6,000 shares at $14.61 on 2024-09-16, exactly doubling his pre-transaction holdings from 6,000 to 12.0K shares. The transaction value of $87,660.00 represents a significant commitment. His prior USCB trade timing is notably consistent: all 4 prior buys at this ticker achieved positive 90-day returns (ranging from +5.1% to +45.5%), demonstrating 100% well-timed entry patterns at the 90-day mark. His cross-ticker track record across all open-market buys shows an average 90-day return of +23.4% with a 100.00% win rate, suggesting a track record of disciplined entry decisions. The current price of $15.32 is within the 52-week range and +3.4% above the 30-day baseline, reflecting modest recent momentum following a +27.4% 90-day advance.